These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

213 related items for PubMed ID: 3935572

  • 1. Non-covalently bound C3 enhances lysis of rabbit erythrocytes through the alternative pathway.
    Hidvégi T, Füst G, Rajnavölgyi E, Kulics J, Gergely J.
    Immunology; 1985 Dec; 56(4):735-41. PubMed ID: 3935572
    [Abstract] [Full Text] [Related]

  • 2. Lysis of horse red blood cells mediated by antibody-independent activation of the alternative pathway of chicken complement.
    Ohta H, Yoshikawa Y, Kai C, Yamanouchi K, Okada H.
    Immunology; 1984 Jul; 52(3):437-44. PubMed ID: 6430791
    [Abstract] [Full Text] [Related]

  • 3. Development and application of an enzyme-linked immunosorbent assay for the quantitation of alternative complement pathway activation in human serum.
    Mayes JT, Schreiber RD, Cooper NR.
    J Clin Invest; 1984 Jan; 73(1):160-70. PubMed ID: 6418767
    [Abstract] [Full Text] [Related]

  • 4. IgG on mouse erythrocytes augments activation of the human alternative complement pathway by enhancing deposition of C3b.
    Moore FD, Fearon DT, Austen KF.
    J Immunol; 1981 May; 126(5):1805-9. PubMed ID: 6908606
    [No Abstract] [Full Text] [Related]

  • 5. A simple alternative pathway for hemolytic assay of human complement component C3 using methylamine-treated plasma.
    Jessen TE, Barkholt V, Welinder KG.
    J Immunol Methods; 1983 May 27; 60(1-2):89-100. PubMed ID: 6406606
    [Abstract] [Full Text] [Related]

  • 6. The third component of complement: covalent attachment of a radioactive sugar to the labile binding site of C3 via the alternative pathway.
    Mann J, O'Brien R, Hostetter MK, Alper CA, Rosen FS, Babior BM.
    J Immunol; 1981 Jun 27; 126(6):2370-2. PubMed ID: 6785350
    [Abstract] [Full Text] [Related]

  • 7. In vitro complement activation by rabbit lymphocytes and thymocytes in autologous serum.
    Wilson AB, Lachmann PJ, Coombs RR.
    Immunology; 1979 May 27; 37(1):25-34. PubMed ID: 112041
    [Abstract] [Full Text] [Related]

  • 8. Extracts of airborne grain dusts activate alternative and classical complement pathways.
    Olenchock SA, Mull JC, Major PC.
    Ann Allergy; 1980 Jan 27; 44(1):23-8. PubMed ID: 6766283
    [Abstract] [Full Text] [Related]

  • 9. Alternative complement pathway-dependent ingestion of fluolite particles by human granulocytes.
    Arnaout MA, Luscinskas FW, Lionetti FJ, Alper CA, Valeri CR.
    J Immunol; 1981 Jul 27; 127(1):278-81. PubMed ID: 6787126
    [Abstract] [Full Text] [Related]

  • 10. Evasion of the alternative complement pathway by metacyclic trypomastigotes of Trypanosoma cruzi: dependence on the developmentally regulated synthesis of surface protein and N-linked carbohydrate.
    Sher A, Hieny S, Joiner K.
    J Immunol; 1986 Nov 01; 137(9):2961-7. PubMed ID: 3531342
    [Abstract] [Full Text] [Related]

  • 11. Antibody restores human alternative complement pathway activation by mouse erythrocytes rendered functionally deficient by pretreatment with pronase.
    Moore FD, Austen KF, Fearon DT.
    J Immunol; 1982 Mar 01; 128(3):1302-6. PubMed ID: 6915957
    [Abstract] [Full Text] [Related]

  • 12. Sheep serum complement sensitisation of sheep erythrocyte-rabbit antibody complexes for haemolysis by guinea-pig complement plus EDTA or Mg2+-EGTA.
    Jonas W, Stankiewicz M.
    Arch Immunol Ther Exp (Warsz); 1986 Mar 01; 34(4):451-60. PubMed ID: 3099725
    [Abstract] [Full Text] [Related]

  • 13. Natural hemolytic and bactericidal activities of sea bream Sparus aurata serum are effected by the alternative complement pathway.
    Sunyer JO, Tort L.
    Vet Immunol Immunopathol; 1995 Apr 01; 45(3-4):333-45. PubMed ID: 7676614
    [Abstract] [Full Text] [Related]

  • 14. Activation of the alternative pathway of complement by Acanthamoeba culbertsoni.
    Ferrante A, Rowan-Kelly B.
    Clin Exp Immunol; 1983 Nov 01; 54(2):477-85. PubMed ID: 6418422
    [Abstract] [Full Text] [Related]

  • 15. Plasmodium gallinaceum: differential lysis of two developmental stages of malaria sporozoites by the alternative pathway of complement.
    Touray MG, Seeley DC, Miller LH.
    Exp Parasitol; 1994 May 01; 78(3):294-301. PubMed ID: 8162961
    [Abstract] [Full Text] [Related]

  • 16. Enhanced reactive lysis of paroxysmal nocturnal hemoglobinuria erythrocytes by C5b-9 does not involve increased C7 binding or cell-bound C3b.
    Rosenfeld SI, Jenkins DE, Leddy JP.
    J Immunol; 1985 Jan 01; 134(1):506-11. PubMed ID: 3964820
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Serotherapy of primary rat mammary carcinoma: inhibition by ethylenedinitrilotetraacetic acid but not by [ethylenebis(oxyethylenenitrilo)]tetraacetic acid.
    Nakanishi K, Zbar B, Borsos T, Glenn G.
    Cancer Res; 1986 Aug 01; 46(8):3886-90. PubMed ID: 3089581
    [Abstract] [Full Text] [Related]

  • 19. [Concentration-functional interrelationships in the human alternative complement activation pathway].
    Galebskaia LV, Shcherbak IG, Bel'tiukov PP, Riumina EV, Solovtsova IL.
    Biokhimiia; 1993 Nov 01; 58(11):1796-800. PubMed ID: 8268316
    [Abstract] [Full Text] [Related]

  • 20. [Selective binding in vitro of a modified form of the C3 component of complement to human erythrocytes].
    Micouin C, Hudry-Clergeon E, Roussel B, Battail N, Tournoud A, Colomb MG.
    Ann Immunol (Paris); 1983 Nov 01; 134C(2):237-53. PubMed ID: 6223572
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.